tradingkey.logo

Pacific Biosciences of California Inc

PACB

1.355USD

+0.025+1.88%
Horarios del mercado ETCotizaciones retrasadas 15 min
406.56MCap. mercado
PérdidaP/E TTM

Pacific Biosciences of California Inc

1.355

+0.025+1.88%
Más Datos de Pacific Biosciences of California Inc Compañía
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Información de la empresa
Símbolo de cotizaciónPACB
Nombre de la empresaPacific Biosciences of California Inc
Fecha de salida a bolsaOct 27, 2010
Director ejecutivoMr. Christian O. Henry
Número de empleados575
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección1305 O'brien Drive
CiudadMENLO PARK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94025
Teléfono16505218000
Sitio Webhttps://www.pacb.com/
Símbolo de cotizaciónPACB
Fecha de salida a bolsaOct 27, 2010
Director ejecutivoMr. Christian O. Henry
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jim R. Gibson
Mr. Jim R. Gibson
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
Por regiónUSD
Nombre
Ganancia
Proporción
North America
16.30M
43.88%
Asia Pacific
11.61M
31.25%
Europe (including the Middle East and Africa)
9.24M
24.87%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
Estadísticas de accionistas
Actualizado: vie., 13 de jun
Actualizado: vie., 13 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
ARK Investment Management LLC
12.10%
Madrone Advisors, LLC
7.80%
SoftBank Group Corp
6.82%
BlackRock Institutional Trust Company, N.A.
6.81%
The Vanguard Group, Inc.
5.40%
Other
61.08%
Accionistas
Accionistas
Proporción
ARK Investment Management LLC
12.10%
Madrone Advisors, LLC
7.80%
SoftBank Group Corp
6.82%
BlackRock Institutional Trust Company, N.A.
6.81%
The Vanguard Group, Inc.
5.40%
Other
61.08%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
46.28%
Investment Advisor/Hedge Fund
11.14%
Holding Company
6.82%
Research Firm
2.18%
Hedge Fund
2.07%
Individual Investor
1.18%
Corporation
1.17%
Bank and Trust
0.50%
Pension Fund
0.26%
Other
28.40%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
600
215.28M
71.74%
-113.79M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
2023Q2
639
248.61M
99.68%
-37.06M
2023Q1
649
249.45M
101.17%
-6.40M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
ARK Investment Management LLC
36.48M
12.16%
+434.08K
+1.20%
Mar 31, 2025
Madrone Advisors, LLC
23.39M
7.8%
--
--
Mar 31, 2025
SoftBank Group Corp
20.45M
6.82%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.44M
6.81%
-1.17M
-5.42%
Mar 31, 2025
The Vanguard Group, Inc.
16.21M
5.4%
+1.04M
+6.83%
Mar 31, 2025
Edmond de Rothschild Asset Management (France) S.A.
21.86M
7.28%
+508.70K
+2.38%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
9.57M
3.19%
-613.17K
-6.02%
Mar 31, 2025
State Street Global Advisors (US)
6.38M
2.13%
-47.38K
-0.74%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.32M
2.11%
+54.32K
+0.87%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
4.89M
1.63%
-8.23K
-0.17%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Genomic Revolution ETF
1.34%
iShares Genomics Immunology and Healthcare ETF
0.75%
Invesco NASDAQ Future Gen 200 ETF
0.58%
Global X Genomics & Biotechnology ETF
0.42%
ARK Innovation ETF
0.41%
WisdomTree BioRevolution Fund
0.31%
AXS Green Alpha ETF
0.27%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
Ver más
ARK Genomic Revolution ETF
Proporción1.34%
iShares Genomics Immunology and Healthcare ETF
Proporción0.75%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.58%
Global X Genomics & Biotechnology ETF
Proporción0.42%
ARK Innovation ETF
Proporción0.41%
WisdomTree BioRevolution Fund
Proporción0.31%
AXS Green Alpha ETF
Proporción0.27%
Invesco Nasdaq Biotechnology ETF
Proporción0.04%
ProShares Ultra Nasdaq Biotechnology
Proporción0.04%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.04%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI